These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 39099260)

  • 41. Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan.
    Davis A; McCrimmon T; Dasgupta A; Gilbert L; Terlikbayeva A; Hunt T; Primbetova S; Wu E; Darisheva M; El-Bassel N
    Int J Drug Policy; 2018 Dec; 62():43-50. PubMed ID: 30359872
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A qualitative study of community home-based care and antiretroviral adherence in Swaziland.
    Root R; Whiteside A
    J Int AIDS Soc; 2013 Oct; 16():17978. PubMed ID: 24107652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors associated with antiretroviral treatment uptake and adherence: a review. Perspectives from Australia, Canada, and the United Kingdom.
    Bolsewicz K; Debattista J; Vallely A; Whittaker A; Fitzgerald L
    AIDS Care; 2015; 27(12):1429-38. PubMed ID: 26641139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perspectives on ART adherence among Zambian adults living with HIV: insights raised using HIV-related disability frameworks.
    Hanass-Hancock J; Bond V; Solomon P; Cameron C; Maimbolwa M; Menon A; Nixon S
    AIDS Care; 2020 May; 32(5):623-629. PubMed ID: 31416343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART and illicit drugs.
    Fuster-RuizdeApodaca MJ; Castro-Granell V; Laguía A; Jaén Á; Cenoz S; Galindo MJ
    AIDS Res Ther; 2020 May; 17(1):24. PubMed ID: 32448214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Moderating Role of HIV Stigma on the Relationship between Perceived Social Support and Antiretroviral Therapy Adherence Self-Efficacy among Adult PLHIV in South Africa.
    Luthuli MQ; John-Langba J
    J Int Assoc Provid AIDS Care; 2024; 23():23259582241228743. PubMed ID: 38594925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between HIV stigma and antiretroviral therapy adherence among adults living with HIV: baseline findings from the HPTN 071 (PopART) trial in Zambia and South Africa.
    Jones HS; Floyd S; Stangl A; Bond V; Hoddinott G; Pliakas T; Bwalya J; Mandla N; Moore A; Donnell D; Bock P; Fidler S; Hayes R; Ayles H; Hargreaves JR;
    Trop Med Int Health; 2020 Oct; 25(10):1246-1260. PubMed ID: 32745296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. "The one who doesn't take ART medication has no wealth at all and no purpose on Earth" - a qualitative assessment of how HIV-positive adults in Uganda understand the health and wealth-related benefits of ART.
    Saya U; MacCarthy S; Mukasa B; Wabukala P; Lunkuse L; Wagner Z; Linnemayr S
    BMC Public Health; 2022 May; 22(1):1056. PubMed ID: 35619119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High self-reported non-adherence to antiretroviral therapy amongst adolescents living with HIV in Malawi: barriers and associated factors.
    Kim MH; Mazenga AC; Yu X; Ahmed S; Paul ME; Kazembe PN; Abrams EJ
    J Int AIDS Soc; 2017 Mar; 20(1):21437. PubMed ID: 28406275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors associated with adherence to antiretroviral therapy among adolescents living with HIV/AIDS in low- and middle-income countries: a systematic review.
    Hudelson C; Cluver L
    AIDS Care; 2015; 27(7):805-16. PubMed ID: 25702789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model.
    Holtzman CW; Shea JA; Glanz K; Jacobs LM; Gross R; Hines J; Mounzer K; Samuel R; Metlay JP; Yehia BR
    AIDS Care; 2015; 27(7):817-28. PubMed ID: 25671515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Adherence reinforcement for antiretroviral therapy: PLHIV's perceptions and experience in Burkina Faso].
    Berthé-Sanou L; Sanou M; Berthé A; Ouédraogo R; Sawadogo AB; Drabo J; Moh R; Tubiana R; Slama L; Desclaux A
    Sante Publique; 2019; 31(6):855-864. PubMed ID: 32550668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Episodic medication adherence in adolescents and young adults with perinatally acquired HIV: a within-participants approach.
    Hawkins A; Evangeli M; Sturgeon K; Le Prevost M; Judd A;
    AIDS Care; 2016; 28 Suppl 1(sup1):68-75. PubMed ID: 26886514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "We give them threatening advice…": expectations of adherence to antiretroviral therapy and their consequences among adolescents living with HIV in rural Malawi.
    Burns R; Magalasi D; Blasco P; Szumilin E; Pasquier E; Schramm B; Wringe A
    J Int AIDS Soc; 2020 Mar; 23(3):e25459. PubMed ID: 32124554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Facilitators and barriers to antiretroviral therapy adherence among HIV-positive adolescents living in Tanzania.
    Audi C; Jahanpour O; Antelman G; Guay L; Rutaihwa M; van de Ven R; Woelk G; Baird SJ
    BMC Public Health; 2021 Dec; 21(1):2274. PubMed ID: 34903209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Persons living with HIV infection on antiretroviral therapy also consulting traditional healers: a study in three African countries.
    Wanyama JN; Tsui S; Kwok C; Wanyenze RK; Denison JA; Koole O; van Praag E; Castelnuovo B; Wabwire-Mangen F; Kwesigabo GP; Colebunders R
    Int J STD AIDS; 2017 Sep; 28(10):1018-1027. PubMed ID: 28162034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentiated Antiretroviral Therapy Delivery: Implementation Barriers and Enablers in South Africa.
    Sharer M; Davis N; Makina N; Duffy M; Eagan S
    J Assoc Nurses AIDS Care; 2019; 30(5):511-520. PubMed ID: 30720561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What makes orphans in Kigali, Rwanda, non-adherent to antiretroviral therapy? Perspectives of their caregivers.
    Kikuchi K; Poudel KC; Muganda J; Sato T; Mutabazi V; Muhayimpundu R; Majyambere A; Nyonsenga SP; Sase E; Jimba M
    J Int AIDS Soc; 2014; 17(1):19310. PubMed ID: 25477050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 'Not taking medications and taking medication, it was the same thing:' perspectives of antiretroviral therapy among people hospitalised with advanced HIV disease.
    Loveday M; Hlangu S; Manickchund P; Govender T; Furin J
    BMC Infect Dis; 2024 Aug; 24(1):819. PubMed ID: 39138390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Barriers and facilitators for adherence to antiretroviral therapy, and strategies to address the barriers in key populations, Mumbai-A qualitative study.
    Acharya S; Parthasarathy MR; Karanjkar V; Katkar S; Setia MS
    PLoS One; 2024; 19(7):e0305390. PubMed ID: 38990894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.